Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation
- PMID: 7931203
- DOI: 10.1097/00005053-199410000-00005
Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation
Abstract
This study compares DSM-III-R lifetime diagnoses assigned to a sample of substance abusers in treatment made by the Computerized Diagnostic Interview Schedule (C-DIS) with those made by clinicians on the basis of the Structured Clinical Interview for DSM-III-R (SCID) and patient chart information. A sample of 173 subjects were interviewed with the C-DIS and then by a clinician using the SCID. A second SCID was administered by a different clinician to 80 of the subjects 1 to 2 weeks later and consensus diagnoses were then made using all available information. With the exception of antisocial personality disorder and most psychoactive substance use disorders, the initial C-DIS showed poor diagnostic agreement with the initial SCID. As a potential screening instrument, the C-DIS did identify 30 of the 32 subjects with a consensus axis I (nondrug) disorder, but diagnosed twice as many positives as were confirmed by the consensus diagnoses. A negative C-DIS for comorbid disorders was confirmed in 9 out of 10 cases by clinicians.
Similar articles
-
Diagnosing comorbidity in substance abusers: a comparison of the test-retest reliability of two interviews.Am J Drug Alcohol Abuse. 1995 May;21(2):167-85. doi: 10.3109/00952999509002686. Am J Drug Alcohol Abuse. 1995. PMID: 7639204 Clinical Trial.
-
Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.Am J Psychiatry. 2004 Jul;161(7):1231-7. doi: 10.1176/appi.ajp.161.7.1231. Am J Psychiatry. 2004. PMID: 15229056
-
Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers.J Nerv Ment Dis. 1999 Aug;187(8):478-86. doi: 10.1097/00005053-199908000-00004. J Nerv Ment Dis. 1999. PMID: 10463065
-
Importance of clinical diagnoses for comorbidity studies in substance use disorders.Neurotox Res. 2006 Dec;10(3-4):253-61. doi: 10.1007/BF03033361. Neurotox Res. 2006. PMID: 17197374 Review.
-
Assessment of comorbid psychiatric illness and substance disorders.New Dir Ment Health Serv. 1991 Summer;(50):43-55. doi: 10.1002/yd.23319915006. New Dir Ment Health Serv. 1991. PMID: 1886549 Review. No abstract available.
Cited by
-
Psychiatric Comorbidity in Patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study.PLoS One. 2013 Jun 18;8(6):e66451. doi: 10.1371/journal.pone.0066451. Print 2013. PLoS One. 2013. PMID: 23823135 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials